Anders Rylander, CEO Biovica comments the Q1 report

Biovica’s CEO Anders Rylander summarizes the first quarter of the company’s fiscal year 2017/18. The interview focuses on the latest recruitments that have been made during the quarter, the DiviTum technology, and regulatory approvals needed for the product in key markets. The interview ends with Anders Rylander commenting on the Biovica strategy until 2019.

 

2017-09-04T10:12:16+00:00 September 4th, 2017 10:30|News|